|
1
|
William BM and Armitage JO: International
analysis of the frequency and outcomes of NK/T-cell lymphomas. Best
Pract Res Clin Haematol. 26:23–32. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang J, Wang WD, Geng QR, Wang L, Chen
XQ, Liu CC and Lv Y: Serum levels of interleukin-9 correlate with
negative prognostic factors in extranodal NK/T-cell lymphoma. PloS
One. 9:e946372014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sun J, Yang Q, Lu Z, He M, Gao L, Zhu M,
Sun L, Wei L, Li M, Liu C, et al: Distribution of lymphoid
neoplasms in China: Analysis of 4,638 cases according to the World
Health Organization classification. Am J Clin Pathol. 138:429–434.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee J, Suh C, Park YH, Ko YH, Bang SM, Lee
JH, Lee DH, Huh J, Oh SY, Kwon HC, et al: Extranodal natural killer
T-cell lymphoma, nasal-type: A prognostic model from a
retrospective multicenter study. J Clin Oncol. 24:612–618. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jo JC, Yoon DH, Kim S, Lee BJ, Jang YJ,
Park CS, Huh J, Lee SW, Ryu JS and Suh C: Clinical features and
prognostic model for extranasal NK/T-cell lymphoma. Eur J Haematol.
89:103–110. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li X, Liao WH, Zhou JH, Liu BA, Wen JF and
Hu ZL: NK/T cell lymphoma involving mediastinum: Report of a case
and review of literature. Int J Clin Exp Pathol. 7:6399–6402.
2014.PubMed/NCBI
|
|
7
|
Wang ZY, Liu QF, Wang H, Jin J, Wang WH,
Wang SL, Song YW, Liu YP, Fang H, Ren H, et al: Clinical
implications of plasma Epstein-Barr virus DNA in early-stage
extranodal nasal-type NK/T-cell lymphoma patients receiving primary
radiotherapy. Blood. 120:2003–2010. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chauchet A, Michallet AS, Berger F,
Bedgedjian I, Deconinck E, Sebban C, Antal D, Orfeuvre H, Corront
B, Petrella T, et al: Complete remission after first-line
radio-chemotherapy as predictor of survival in extranodal NK/T cell
lymphoma. J Hematol Oncol. 5:272012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ma HH, Qian LT, Pan HF, Yang L, Zhang HY,
Wang ZH, Ma J, Zhao YF, Gao J and Wu AD: Treatment outcome of
radiotherapy alone versus radiochemotherapy in early stage nasal
natural killer/T-cell lymphoma. Med Oncol. 27:798–806. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang B, Zhu F, Liu X, Zhao J, Li M, Li Y,
Huang J, Zou L and Chang Q: Radiotherapy combined with chemotherapy
versus radiotherapy alone for early stage nasal natural
killer/T-cell lymphoma: A meta-analysis. J Chemother. 28:65–71.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
National Comprehensive Cancer Network, .
NCCN Clinical Practice Guidelines in Oncology: Non-Hodgkin's
Lymphomas, Version 2. 2015.https://www.nccn.org/about/nhl.pdfAccessed July
13, 2015.
|
|
12
|
Swerdlow SH, Campo E, Harris NL, Jaffe ES,
Pileri SA, Stein H, Thiele J and Vardiman JW: WHO classification of
tumours of haematopoietic and lymphoid tissues. 2. 4th. World
Health Organization; 2008
|
|
13
|
Kim SJ, Hong M, Do IG, Lee SH, Ryu KJ, Yoo
HY, Hong JY, Ko YH and Kim WS: Serum survivin and vascular
endothelial growth factor in extranodal NK/T-cell lymphoma, nasal
type: Implications for a potential new prognostic indicator.
Haematologica. 100:e106–e109. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li YX, Wang H, Jin J, Wang WH, Liu QF,
Song YW, Wang ZY, Qi SN, Wang SL, Liu YP, et al: Radiotherapy alone
with curative intent in patients with stage I extranodal nasal-type
NK/T-cell lymphoma. Int J Radiat Oncol Biol Phys. 82:1809–1815.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li YX, Liu QF, Wang WH, Jin J, Song YW,
Wang SL, Liu YP, Liu XF, Zhou LQ and Yu ZH: Failure patterns and
clinical implications in early stage nasal natural killer/T-cell
lymphoma treated with primary radiotherapy. Cancer. 117:5203–5211.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Au WY, Weisenburger DD, Intragumtornchai
T, Nakamura S, Kim WS, Sng I, Vose J, Armitage JO and Liang R:
International Peripheral T-Cell Lymphoma Project: Clinical
differences between nasal and extranasal natural killer/T-cell
lymphoma: A study of 136 cases from the International Peripheral
T-Cell Lymphoma Project. Blood. 113:3931–3937. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Obama K: Concomitant use of radiotherapy
and two topoisomerase inhibitors to treat adult T-cell leukemia
with a radiotherapy-resistant bulky disease: A case series. Am J
Blood Res. 4:106–109. 2014.PubMed/NCBI
|
|
18
|
Kwong YL, Kim WS, Lim ST, Kim SJ, Tang T,
Tse E, Leung AY and Chim CS: SMILE for natural killer/T-cell
lymphoma: Analysis of safety and efficacy from the Asia Lymphoma
Study Group. Blood. 120:2973–2980. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lim YL, Pack HS, Park JE, Oh JR and Kong
JH: Extranodal natural killer/T-cell lymphoma of the tenosynovium
of the hand. Korean J Intern Med. 30:122–124. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamaguchi M, Kwong YL, Kim WS, Maeda Y,
Hashimoto C, Suh C, Izutsu K, Ishida F, Isobe Y, Sueoka E, et al:
Phase II study of SMILE chemotherapy for newly diagnosed stage IV,
relapsed, or refractory extranodal natural killer (NK)/T-cell
lymphoma, nasal type: The NK-Cell Tumor Study Group study. J Clin
Oncol. 29:4410–4416. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
LaPorte J, Morris L and Koepke J: Long
complete remission achieved with the combination therapy of
Cisplatin and gemcitabine in a patient with aggressive natural
killer cell leukemia. Case Rep Hematol. 2015:7156152015.PubMed/NCBI
|
